全球數位 PCR 市場規模、佔有率、成長分析，依技術（液滴數位 PCR 和基於晶片的數位 PCR）、產品類型、應用 - 產業預測 2024-2031

2022 年全球數位 PCR 市場規模預計為 59.5 億美元，預計將從 2023 年的 64.9 億美元成長到 2031 年的 130.7 億美元，預測期內（2024-2031 年）複合年成長率為 9.14%。

由於對精確核酸定量和分析的需求不斷成長，全球數位 PCR（聚合酶鍊式反應）市場正在經歷快速成長。數位 PCR 以其無與倫比的準確性和靈敏度而聞名，是基因檢測、疾病診斷和研究工作的重要工具，旨在提供先進的分子診斷解決方案。主要促進因素包括遺傳性疾病和傳染病的盛行率不斷上升，以及對個人化醫療和基因組研究進展的需求激增。儘管如此，數位 PCR 儀器的高成本和最終用戶意識有限等課題阻礙了市場的發展。值得注意的趨勢包括數位 PCR 與下一代定序技術的整合以及用於同時檢測各種目標的多重數位 PCR 檢測的開發。儘管存在障礙，但新興經濟體採用率的提高、腫瘤學和傳染病診斷應用的擴大以及功能增強的創新產品的推出，仍帶來了巨大的擴展機會。

目錄

執行摘要

• 市場概況
• 命運之輪

研究方法論

• 資訊採購
• 二手和主要資料來源
• 市場規模估計
• 市場假設與限制

母公司市場分析

• 市場概況
• 市場規模
• 市場動態
  • 促進要素
  • 機會
  • 限制
  • 課題

主要市場洞察

• 技術分析
• 定價分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 智慧財產權分析
• 貿易分析
• 啟動分析
• 原料分析
• 創新矩陣
• 管道產品分析
• 總體經濟指標
• 頂級投資分析
• 成功的關鍵因素
• 競爭程度

市場動態與展望

• 市場動態
  • 促進要素
  • 機會
  • 限制
  • 課題
• 監管環境
• 波特分析
• 對未來顛覆的特別見解

依技術分類的全球數位 PCR 市場

• 市場概況
• 液滴數位 PCR (ddPCR) 和晶片數位 PCR (cdPCR)

依產品類型分類的全球數位 PCR 市場

• 市場概況
• 儀器
• 試劑及耗材
• 軟體和服務

依應用分類的全球數位 PCR 市場

• 市場概況
• 臨床診斷
• 研究
• 法醫
• 和環境監測影像

全球數位 PCR 市場規模（依地區）

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 拉丁美洲其他地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • MEA 的其餘部分

競爭格局

• 前 5 名企業比較
• 2021 年關鍵參與者的市場定位
• 主要市場參與者所採取的策略
• 最佳制勝策略
• 近期市集活動
• 主要公司市佔率（%），2021年

主要公司簡介

• Thermo Fisher Scientific (US)
• Bio-Rad Laboratories (US)
• QIAGEN (Germany)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Fluidigm Corporation (US)
• Merck KGaA (Germany)
• Agilent Technologies (US)
• BioMA(C)rieux SA (France)
• Takara Bio Inc. (Japan)
• Danaher Corporation (US)
• JN Medsys (Singapore)
• RainDance Technologies (US)
• Formulatrix, Inc. (US)
• Stilla Technologies (France)
• Becton, Dickinson and Company (US)
• Analytik Jena AG (Germany)
• Douglas Scientific (US)
• Sysmex Corporation (Japan)
• GenMark Diagnostics, Inc. (US)
• Quantabio (US)

Global Digital PCR Market size was valued at USD 5.95 Billion in 2022 and is poised to grow from USD 6.49 Billion in 2023 to USD 13.07 Billion by 2031, at a CAGR of 9.14% during the forecast period (2024-2031).

The Global Digital PCR (Polymerase Chain Reaction) Market is experiencing rapid growth due to rising demand for precise nucleic acid quantification and analysis. Digital PCR, known for its unmatched accuracy and sensitivity, serves as a vital tool in genetic testing, disease diagnosis, and research endeavors, aiming to provide advanced molecular diagnostic solutions. Key drivers include the escalating prevalence of genetic disorders and infectious diseases, alongside a surge in demand for personalized medicine and genomic research advancements. Nonetheless, challenges such as the high cost of digital PCR instruments and limited end-user awareness hinder market progression. Noteworthy trends involve the integration of digital PCR with next-generation sequencing technologies and the development of multiplex digital PCR assays for simultaneous detection of various targets. Despite obstacles, significant expansion opportunities arise from increased adoption in emerging economies, widening applications in oncology and infectious disease diagnostics, and the introduction of innovative products with enhanced features.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital PCR Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital PCR Market Segmental Analysis

Global Digital PCR Market is segmented on the basis of technology, product type, application, and region. By technology, the market is segmented into droplet digital PCR (ddPCR) and chip-based digital PCR (cdPCR). By product type, the market is segmented into instruments, reagents and consumables, and software and services. By application, the market is segmented into clinical diagnostics, research, forensics, and environmental monitoring. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Digital PCR Market

The significant growth of the market for digital polymerase chain reaction (dPCR) is being propelled by remarkable technological advancements. This evolution from traditional PCR techniques enables direct quantification and clonal amplification of nucleic acids, meeting the rising demand for more precise and efficient diagnostic tools. With a surge in research and development efforts, diverse PCR technologies are emerging, presenting substantial advantages and driving further innovation in the field.

Restraints in the Global Digital PCR Market

The widespread uptake of digital PCR technology might encounter obstacles due to the substantial initial expenses linked with acquiring instruments and reagents. Digital PCR platforms demand specialized equipment and consumables, which could pose a financial challenge for research labs or smaller healthcare institutions. Such high expenditures might restrict the availability of digital PCR technology, especially in resource-constrained environments or for researchers facing budgetary limitations.

Market Trends of the Global Digital PCR Market

The integration of digital PCR and NGS technologies offers a comprehensive approach to genomic analysis, as they complement each other effectively. By combining digital PCR's precise quantification with NGS's sequencing capabilities, researchers can acquire both qualitative and quantitative genomic insights. This integrated approach enables the detection of rare genetic variants, validation of NGS findings, and thorough analysis of intricate genomic changes associated with various diseases.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Digital PCR Market by Technology

• Market Overview
• droplet digital PCR (ddPCR) and chip-based digital PCR (cdPCR)

Global Digital PCR Market by Product Type

• Market Overview
• instruments
• reagents and consumables
• and software and services

Global Digital PCR Market by Application

• Market Overview
• clinical diagnostics
• research
• forensics
• and environmental monitoring Image

Global Digital PCR Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMA(C)rieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JN Medsys (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RainDance Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Formulatrix, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stilla Technologies (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Analytik Jena AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Douglas Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quantabio (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments